Next-generation RNA drugmaker Alltrna has raised a $109 million Series B round, the Flagship Pioneering-incubated company announced Wednesday.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,